 Deutsche Bank AG cut its position in Kezar Life Sciences Inc NASDAQ:KZR by 24.0 during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,173 shares of the companys stock after selling 7,318 shares during the period. Deutsche Bank AG owned approximately 0.06 of Kezar Life Sciences ... 